Viewing nowFluoracil Tablets (Metronidazole)
Metronidazole 250mg
Tablet · Prescription medication
H.K. Inno.N Co., Ltd.

MFDS item code 196500004 · Notified 1965.08.16 · Insurance code 640002760
Treatment of anaerobic bacterial infections, trichomoniasis, and amebiasis; prevention of postoperative infections
This medication is effective for treating parasitic infections such as trichomoniasis and amoebiasis. It is also used for abdominal infections such as peritonitis, intra-abdominal abscess, and liver abscess, as well as skin and skin tissue infections and gynecological infections such as endometritis. It is effective in severe infection conditions such as sepsis, brain abscess, pneumonia, and bone and joint infections, and plays an important role in treating infections caused by anaerobic bacteria and in preventing postoperative infections. This drug is effective against various bacteremias and necrotizing pneumonia, and osteomyelitis due to its sensitivity to anaerobic Bacteroides and Streptococcus species. It is used to improve and treat infections in complex and diverse infection states.
(Tablets) Trichomoniasis: The usual adult dose is 250 mg of metronidazole per dose, taken orally twice daily for 10 days. Treatment of anaerobic bacterial infections: The usual adult dose is 500 mg of this medicine per dose, taken orally 3 ∼ 4 times daily. Do not exceed a maximum daily dose of 4 g; treatment generally lasts 7 ∼ 10 days. Postoperative prophylaxis of anaerobic bacterial infections: The usual adult initial dose is 1 g of this medicine, followed by 250 mg per dose orally 3 times daily. Amebiasis: The usual adult dose is 500 ∼ 750 mg of this medicine per dose, taken orally 3 times daily for 5 ~ 10 days. (Injection) Administer the following doses by slow intravenous injection at a rate of 25 mg (5 mL) per minute. Replace with an oral preparation as soon as possible once the patient's condition improves. Treatment of anaerobic bacterial infections Adults: Inject 500 mg (100 mL) of metronidazole intravenously every 8 hours. Once oral administration is possible, switch to oral metronidazole 500 mg 3 times daily. The total duration of injection treatment should not exceed 7 days, although extension of treatment may be considered based on clinical and bacteriological evaluation. Prophylaxis of postoperative infections caused by anaerobic bacteria (Use of this regimen is generally limited to 24 hours, and at most 48 hours.) Adults: Administer 500 mg (100 mL) of this medicine intravenously every 8 hours immediately before, during, or after surgery. Once oral administration is possible, switch to oral metronidazole 250 mg per dose, 3 times daily.
Treatment of anaerobic bacterial infections — Children 12 years and older: Inject 500 mg (100 mL) of metronidazole intravenously every 8 hours. Once oral administration is possible, switch to oral metronidazole 500 mg 3 times daily. The total duration of injection treatment should not exceed 7 days, although extension of treatment may be considered based on clinical and bacteriological evaluation. Treatment of anaerobic bacterial infections — Children under 12 years: Administer 3 times daily; the intravenous dose per administration is 7.5 mg (1.5 mL) of this medicine per kg of body weight, and the oral dose per administration is also 7.5 mg/kg of metronidazole. Treatment of anaerobic bacterial infections — Infants under 8 weeks: Administer twice daily. Prophylaxis of postoperative infections caused by anaerobic bacteria — Children 12 years and older: Administer 500 mg (100 mL) of this medicine intravenously every 8 hours immediately before, during, or after surgery. Once oral administration is possible, switch to oral metronidazole 250 mg per dose, 3 times daily. Prophylaxis of postoperative infections caused by anaerobic bacteria — Children under 12 years: Administer 3 times daily; the preoperative intravenous dose is 7.5 mg (1.5 mL) of this medicine per kg of body weight, and administer 3.7 mg/kg during or after surgery.
This drug should be avoided due to reports of tumorigenicity in rodent studies. In patients with cocaine syndrome, there is an increased risk of hepatotoxicity, so liver function tests must be performed before, during, and after treatment, and therapy should be discontinued immediately if liver function worsens. This medication should not be used in cases of hypersensitivity to it, blood disorders, neurological diseases, early pregnancy, or during breastfeeding. In particular, taking it with alcohol may lead to severe reactions, so alcohol consumption should be avoided for 3 days during and after administration. Patients with impaired kidney or liver function should use this drug cautiously, and adverse reactions such as skin rash, gastrointestinal problems, neurological symptoms, and blood anomalies may occur, requiring careful monitoring. If symptoms such as confusion, drowsiness, hallucinations, or seizures appear, avoid driving or operating machinery, and regular examinations are recommended for use beyond 10 days. This drug may interact with other medications, so if you are taking other drugs, consult your doctor or pharmacist. Do not use in early pregnancy, and avoid breastfeeding for more than 24 hours after administration.
Rash, itching, erythema, hives, fever, angioedema, erythema multiforme, anaphylaxis, shock, pustular rash, fixed drug eruption, Stevens-Johnson syndrome, toxic epidermal necrolysis, acute generalized exanthematous pustulosis, pancreatitis, oral mucositis, taste disorder, loss of appetite, nausea, vomiting, abdominal discomfort, diarrhea, abdominal pain, lumbago, elevated serum amylase levels, leukopenia, neutropenia, agranulocytosis, thrombocytopenia, convulsive seizures, dysarthria, sensory disturbances, confusion, cerebellar ataxia, headache, seizures, dizziness, syncope, peripheral sensory neuropathy, encephalopathy, subacute cerebellar syndrome, disorientation, hallucinations, mental disorder, depressive mood, diplopia, myopia, elevated liver enzyme levels, jaundice, cholestatic hepatitis, urinary disorders, cystitis, polyuria, urinary incontinence, dark urine, dysbiosis, hearing impairment, hearing loss, tinnitus, aseptic meningitis
Not everyone experiences these, and they can vary from person to person.
This drug should be stored in a tightly closed container to prevent contact with air or moisture. It should also be kept away from direct sunlight and stored safely at normal room temperature.
White circular tablet
500 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowMetronidazole 250mg
Tablet · Prescription medication
H.K. Inno.N Co., Ltd.
Metronidazole 500mg
Prescription medication
JW Pharmaceutical Co., Ltd.
Metronidazole 5000mg
Prescription medication
Daehan Pharmaceutical Co., Ltd.
Metronidazole 500mg
Prescription medication
Albozen Korea Co., Ltd.
Metronidazole 7.5mg
Prescription medication
BC World Pharmaceutical Co., Ltd.
Metronidazole 0.75g
Prescription medication
Galderma Korea Co., Ltd.
Metronidazole 500mg
Prescription medication
Bentiv Korea Co., Ltd.
Metronidazole
Prescription medication
NanoPharm Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.